Cytokine levels in the serum of healthy subjects

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Kleiner, Giulio ^a   Marcuzzi, Annalisa ^a   Zanin, Valentina ^a   Monasta, Lorenzo ^a   Zauli, Giorgio ^a  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; CHEMOKINE; COLONY STIMULATING FACTOR 1; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 16; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; LYMPHOTOXIN; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; VASCULOTROPIN; ALPHA INTERFERON; LEUKEMIA INHIBITORY FACTOR; LIF PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD LEVEL; CHILD; CYTOKINE PRODUCTION; DOWN REGULATION; HUMAN; INFANT; NORMAL HUMAN; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; UPREGULATION; BLOOD; FEMALE; MALE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HUMANS; INFANT; INTERFERON-ALPHA; INTERLEUKIN-12; INTERLEUKIN-15; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; INTERLEUKIN-3; INTERLEUKIN-5; LEUKEMIA INHIBITORY FACTOR; LYMPHOTOXIN-ALPHA; MALE;

EID: 84875449748     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/434010     Document Type: Article

References (22)

1. Wong M. M., Fish E. N., Chemokines: attractive mediators of the immune response. Seminars in Immunology 2003 15 1 5 14 2-s2.0-0037300378 10.1016/S1044-5323(02)00123-9 (Pubitemid 36092174)
2. Raman D., Sobolik-Delmaire T., Richmond A., Chemokines in health and disease. Experimental Cell Research 2011 317 5 575 589 2-s2.0-79952104164 10.1016/j.yexcr.2011.01.005
3. Härtel C., Adam N., Strunk T., Temming P., Müller-Steinhardt M., Schultz C., Cytokine responses correlate differentially with age in infancy and early childhood. Clinical and Experimental Immunology 2005 142 3 446 453 2-s2.0-28344434529 10.1111/j.1365-2249.2005.02928.x (Pubitemid 41719840)
4. Benahmed M., Meresse B., Arnulf B., Barbe U., Mention J. J., Verkarre V., Allez M., Cellier C., Hermine O., Cerf-Bensussan N., Inhibition of TGF- β signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 2007 132 3 994 1008 2-s2.0-33947322862 10.1053/j.gastro.2006.12.025 (Pubitemid 46440858)
5. Hartgring S. A. Y., Bijlsma J. W. J., Lafeber F. P. J. G., Van Roon J. A. G., Interleukin-7 induced immunopathology in arthritis. Annals of the Rheumatic Diseases 2006 65 supplement 3 iii69 iii74 2-s2.0-33750375082 10.1136/ard.2006.058479 (Pubitemid 44629108)
6. Alam A., Pal C., Goyal M., Synthesis and bio-evaluation of human macrophage migration inhibitory factor inhibitor to develop anti-inflammatory agent. Bioorganic & Medicinal Chemistry 2011 19 24 7365 7373
7. Garin A., Proudfoot A. E. I., Chemokines as targets for therapy. Experimental Cell Research 2011 317 5 602 612 2-s2.0-79952092865 10.1016/j.yexcr.2010.12.021
8. Braun J., Baraliakos X., Brandt J., Listing J., Zink A., Alten R., Burmester G., Gromnica-Ihle E., Kellner H., Schneider M., Sörensen H., Zeidler H., Sieper J., Persistent clinical response to the anti-TNF- α antibody infliximab in patients with ankylosing spondylitis over 3 years. Rheumatology 2005 44 5 670 676 2-s2.0-21244449214 10.1093/rheumatology/keh584 (Pubitemid 41487242)
9. Rutgeerts P., Sandborn W. J., Feagan B. G., Reinisch W., Olson A., Johanns J., Travers S., Rachmilewitz D., Hanauer S. B., Lichtenstein G. R., De Villiers W. J. S., Present D., Sands B. E., Colombel J. F., Infliximab for induction and maintenance therapy for ulcerative colitis. New England Journal of Medicine 2005 353 23 2462 2476 2-s2.0-28844473957 10.1056/NEJMoa050516 (Pubitemid 41770166)
10. Woolacott N., Bravo Vergel Y., Hawkins N., Kainth A., Khadjesari Z., Misso K., Light K., Asseburg C., Palmer S., Claxton K., Bruce I., Sculpher M., Riemsma R., Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health Technology Assessment 2006 10 31 1 239 2-s2.0-37649019782
11. Keating G. M., Perry C. M., Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis. BioDrugs 2002 16 2 111 148 2-s2.0-0036096689 (Pubitemid 34533773)
12. Rubbert-Roth A., Assessing the safety of biologic agents in patients with rheumatoid arthritis. Rheumatology 2012 51 supplement 5 38 47 10.1093/rheumatology/kes114
13. Calligaris L., Marchetti F., Tommasini A., Ventura A., The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever. European Journal of Pediatrics 2008 167 6 695 696 2-s2.0-41849105723 10.1007/s00431-007-0547-3 (Pubitemid 351503491)
14. So A., De Smedt T., Revaz S., Tschopp J., A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Research and Therapy 2007 9 2 R28 2-s2.0-34047174085 10.1186/ar2143 (Pubitemid 46511126)
15. Fitzgerald A. A., LeClercq S. A., Yan A., Homik J. E., Dinarello C. A., Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis and Rheumatism 2005 52 6 1794 1803 2-s2.0-18644370644 10.1002/art.21061 (Pubitemid 40852888)
16. Dostert C., Pétrilli V., Van Bruggen R., Steele C., Mossman B. T., Tschopp J., Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008 320 5876 674 677 2-s2.0-43249125839 10.1126/science.1156995 (Pubitemid 351928351)
17. Busse W. W., Ring J., Huss-Marp J., Kahn J. E., A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma. Journal of Allergy and Clinical Immunology 2010 125 4 803 813 2-s2.0-77950271175 10.1016/j.jaci.2009.11.048
18. Goldbach-Mansky R., Immunology in clinic review series, focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1. Clinical & Experimental Immunology 2012 167 3 391 404
19. Zanzi D., Stefanile R., Santagata S., Iaffaldano L., Iaquinto G., Giardullo N., Lania G., Vigliano I., Vera A. R., Ferrara K., Auricchio S., Troncone R., Mazzarella G., IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in celiac disease. American Journal of Gastroenterology 2011 106 7 1308 1317 2-s2.0-79960062797 10.1038/ajg.2011.80
20. Takatsu K., Interleukin-5 and IL-5 receptor in health and diseases. Proceedings of the Japan Academy B 2011 87 8 463 485
21. McCombe P. A., Greer J. M., Mackay I. R., Sexual dimorphism in autoimmune disease. Current Molecular Medicine 2009 9 9 1058 1079 2-s2.0-73249123513 10.2174/156652409789839116
22. Lleo A., Battezzati P. M., Selmi C., Gershwin M. E., Podda M., Is autoimmunity a matter of sex? Autoimmunity Reviews 2008 7 8 626 630 2-s2.0-51749110645 10.1016/j.autrev.2008.06.009